- Home
- BNR vs ANVS Comparison
BNR vs ANVS Comparison
Compare BNR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- ANVS
- Stock Information
- Founded
- BNR 2014
- ANVS 2008
- Country
- BNR China
- ANVS United States
- Employees
- BNR N/A
- ANVS N/A
- Industry
- BNR Medical Specialities
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- ANVS Health Care
- Exchange
- BNR Nasdaq
- ANVS Nasdaq
- Market Cap
- BNR 29.1M
- ANVS 24.2M
- IPO Year
- BNR 2020
- ANVS 2020
- Fundamental
- Price
- BNR $3.25
- ANVS $1.98
- Analyst Decision
- BNR
- ANVS Strong Buy
- Analyst Count
- BNR 0
- ANVS 5
- Target Price
- BNR N/A
- ANVS $34.75
- AVG Volume (30 Days)
- BNR 68.1K
- ANVS 345.3K
- Earning Date
- BNR 06-02-2025
- ANVS 05-13-2025
- Dividend Yield
- BNR N/A
- ANVS N/A
- EPS Growth
- BNR N/A
- ANVS N/A
- EPS
- BNR N/A
- ANVS N/A
- Revenue
- BNR $70,669,261.00
- ANVS N/A
- Revenue This Year
- BNR $136.32
- ANVS N/A
- Revenue Next Year
- BNR N/A
- ANVS N/A
- P/E Ratio
- BNR N/A
- ANVS N/A
- Revenue Growth
- BNR N/A
- ANVS N/A
- 52 Week Low
- BNR $2.18
- ANVS $1.11
- 52 Week High
- BNR $7.90
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- BNR 57.77
- ANVS 61.01
- Support Level
- BNR $2.49
- ANVS $1.96
- Resistance Level
- BNR $3.05
- ANVS $2.20
- Average True Range (ATR)
- BNR 0.34
- ANVS 0.20
- MACD
- BNR 0.15
- ANVS 0.05
- Stochastic Oscillator
- BNR 87.61
- ANVS 71.79
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.